Novartis to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indications
Novartis announced today that it has exercised an option to in-license ECF843 for ophthalmic indications worldwide (outside Europe). The closing of the deal is...
Kyowa Hakko Kirin Announces Positive Results of the Phase 3 Clinical Study of Mogamulizumab (KW-0761)
Kyowa Hakko Kirin Co., Ltd. announced the Global Phase 3 study (MAVORIC: Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the use of mogamulizumab (KW-0761)...
Sumitomo announces Partnership with Bukwang on its Atypical Antipsychotic Agent Lurasidone for Korea
Sumitomo Dainippon Pharma Co., Ltd. announced that the Company has concluded a license agreement with Bukwang Pharmaceutical Co., Ltd. relating to the development,sales...
Takeda Completes Enrollment of Large Global Phase 3 Trial for Dengue Vaccine Candidate
Takeda Pharmaceutical Company Limited announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16in its global, pivotal Phase 3...
Teva announces FDA approval of Austedo tablets for chorea associated with huntington’s disease
Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA has approved AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated with Huntington’s disease (HD)....
Aurinia Announces Development Plans for Voclosporin in Europe and Japan
Aurinia Pharmaceuticals Inc announced the outcome of discussions with both the EMA and the PMDA in Japan regarding the development of voclosporin for the...
College of Pharmacy, IBM help next generation of pharmacists utilize Business Intelligence Technologies
IBM and Lipscomb University College of Pharmacy announced an initiative to help train the next-generation of pharmacists on business analytics and insight-derived decision making....
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...